The influence of iron on bone metabolism disorders
- 19 October 2023
- journal article
- review article
- Published by Springer Nature in Osteoporosis International
- Vol. 35 (2) , 243-253
Abstract
Iron is a necessary trace element in the human body, and it participates in many physiological processes. Disorders of iron metabolism can cause lesions in many tissues and organs, including bone. Recently, iron has gained attention as an independent factor influencing bone metabolism disorders, especially the involvement of iron overload in osteoporosis. The aim of this review was to summarize the findings from clinical and animal model research regarding the involvement of iron in bone metabolism disorders and to elucidate the mechanisms behind iron overload and osteoporosis. Lastly, we aimed to describe the association between bone loss and iron overload. We believe that a reduction in iron accumulation can be used as an alternative treatment to assist in the treatment of osteoporosis, to improve bone mass, and to improve the quality of life of patients.Keywords
Funding Information
- National Key R&D Program of China (2021YFC2501702)
This publication has 78 references indexed in Scilit:
- Dancing with sex hormones, could iron contribute to the gender difference in osteoporosis?Bone, 2013
- Bone loss caused by iron overload in a murine model: importance of oxidative stressBlood, 2010
- Hypophosphatemia induced by intravenous administration of saccharated ferric oxideBone, 2009
- FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective StudyThe Journal of Clinical Endocrinology & Metabolism, 2009
- Ferritin Prevents Calcification and Osteoblastic Differentiation of Vascular Smooth Muscle CellsJournal of the American Society of Nephrology, 2009
- Promotion of osteogenesis through β-catenin signaling by desferrioxamineBiochemical and Biophysical Research Communications, 2008
- Iron loading: a risk factor for osteoporosisBioMetals, 2006
- The Intestinal Heme Transporter RevealedCell, 2005
- Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descentBritish Journal of Haematology, 2004
- Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosisNature Genetics, 2002